Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/6200
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Craig Wallington-Gates | en |
dc.contributor.author | Lisa M. Ebert | en |
dc.contributor.author | Kate Vandyke | en |
dc.contributor.author | M. Zahied Johan | en |
dc.contributor.author | Mark DeNichilo | en |
dc.contributor.author | Lih Y. Tan | en |
dc.contributor.author | Kay K. Myo Min | en |
dc.contributor.author | Benjamin M. Weimann | en |
dc.contributor.author | Brenton W. Ebert | en |
dc.contributor.author | Stuart M. Pitson | en |
dc.contributor.author | Andrew C. W. Zannettino | en |
dc.contributor.author | Claudine S. Bonder | en |
dc.date.accessioned | 2024-08-08T03:26:11Z | - |
dc.date.available | 2024-08-08T03:26:11Z | - |
dc.date.issued | 2021 | - |
dc.identifier.citation | Molecular Oncology, 2021, Volume 16 (6), p.1221-1240 | en |
dc.identifier.uri | https://dora.health.qld.gov.au/qldresearchjspui/handle/1/6200 | - |
dc.language.iso | en | en |
dc.publisher | Wiley | en |
dc.title | Desmoglein‐2 expression is an independent predictor of poor prognosis patients with multiple myeloma | en |
dc.type | Article | en |
dc.identifier.doi | 10.1002/1878-0261.13055 | - |
dc.rights.holder | Craig Wallington-Gates | en |
dc.identifier.journaltitle | Molecular Oncology | - |
dc.identifier.external | 96818419 | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.languageiso639-1 | en | - |
item.openairetype | Article | - |
Appears in Sites: | Sunshine Coast HHS Publications |
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.